Voxel-resolution myocardial blood flow analysis
First Claim
1. A method for estimating myocardial blood flow, the method comprising:
- a processing device applying a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes;
incorporating a three-compartment kinetic model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model without assumption that a right ventricle tissue curve and a left ventricle tissue curve obey a particular mathematical relationship by discretizing a continuous time model of the changing concentrations of the bound fluid based tracers, the unbound fluid based tracers, and the blood plasma into a discrete time model using non-negative iterate values for the right ventricle tissue curve and the left ventricle tissue curve and non-negative factor weights, and;
the processing device outputting a processed data set based on the application of the pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium.
1 Assignment
0 Petitions
Accused Products
Abstract
A myocardial blood flow analysis scan includes incorporating a pharmacological kinetic model with the standard factor analysis model where each time activity curve is assumed to be a linear combination of factor curves. Pharmacological kinetics based factor analysis of dynamic structures (K-FADS-II) model can be applied, whereby estimating factor curves in the myocardium can be physiologically meaningful is provided. Additional optional aspects include performing a discretization to transform continuous-time K-FADS-II model into a discrete-time K-FADS-II model and application of an iterative Improved Voxel-Resolution myocardial blood flow (IV-MBF) algorithm. Where the model is applied without assumption that a right ventricle tissue curve and a left ventricle tissue curve obey a particular mathematical relationship, a least squares objective function can be applied to obtain estimates for parameters of the pharmacological kinetic model by applying a majorize-minimize optimization technique to iteratively estimate the curves.
29 Citations
20 Claims
-
1. A method for estimating myocardial blood flow, the method comprising:
-
a processing device applying a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes; incorporating a three-compartment kinetic model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model without assumption that a right ventricle tissue curve and a left ventricle tissue curve obey a particular mathematical relationship by discretizing a continuous time model of the changing concentrations of the bound fluid based tracers, the unbound fluid based tracers, and the blood plasma into a discrete time model using non-negative iterate values for the right ventricle tissue curve and the left ventricle tissue curve and non-negative factor weights, and; the processing device outputting a processed data set based on the application of the pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A non-transitory computer readable medium storing instructions that cause a processing device, in response to executing the instructions, to perform operations comprising:
-
the processing device applying a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes; incorporating a three-compartment kinetic model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model without assumption that a right ventricle tissue curve and a left ventricle tissue curve obey a particular mathematical relationship by discretizing a continuous time model of the changing concentrations of the bound fluid based tracers, the unbound fluid based tracers, and the blood plasma into a discrete time model using non-negative iterate values for the right ventricle tissue curve and the left ventricle tissue curve and non-negative factor weights, and; the processing device outputting a processed data set based on the application of the pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. An apparatus comprising:
-
a processing device configured to apply a pharmacological kinetic model to a data set stored in a storage device, the data set derived from an imaging technique based on monitoring fluid based tracers in a left ventricle, a right ventricle, and myocardium, wherein the pharmacological kinetic model includes; incorporating a three-compartment kinetic model of changing concentrations of bound fluid based tracers, unbound fluid based tracers, and blood plasma fluid based tracers into a standard factor analysis of dynamic structures model without assumption that a right ventricle tissue curve and a left ventricle tissue curve obey a particular mathematical relationship by discretizing a continuous time model of the changing concentrations of the bound fluid based tracers, the unbound fluid based tracers, and the blood plasma into a discrete time model using non-negative iterate values for the right ventricle tissue curve and the left ventricle tissue curve and non-negative factor weights, and; the processing device configured to output a processed data set based on the application of the pharmacological kinetic model to the data set for providing a representation of blood flow in the myocardium. - View Dependent Claims (16, 17, 18, 19, 20)
-
Specification